基本信息
浏览量:2
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
个人简介
1. New genetic tools for the human microbiota. We have developed the first CRISPR-Cas9 based genetic system for a Clostridium commensal Clostridium sporogenes. We are interested in applying the CRISPR-Cas9 technology to other gut bacteria that have shown a strong correlation with human health and disease but are currently not genetically tractable.
2. Modulating microbiota metabolites in the host and study their effects on host biology. An increasing number of studies are revealing important connections between microbiome-derived metabolites and human diseases like inflammatory bowel disease and colon cancer. We will focus on a group of molecules that are derived via microbial fermentation of nutrients (e.g. propionate and butyrate). These molecules are highly abundant and circulatory (have body-wide effects) in the body and their levels can be manipulated via genetic engineering of the gut microbiome. We will apply the genetic tools in the lab to toggle on/off these microbiota metabolites in vivo and investigate their effects on host intestinal immunity and IBD development.
3. Regulating the metabolic interaction between host and gut microbiota. The microbiome is one of the key orchestrators in mediating human health. We will use bioinformatics and molecular genetics to design and engineer a microbiota community for a predefined function in regulating host intestinal immunity for IBD treatment.
2. Modulating microbiota metabolites in the host and study their effects on host biology. An increasing number of studies are revealing important connections between microbiome-derived metabolites and human diseases like inflammatory bowel disease and colon cancer. We will focus on a group of molecules that are derived via microbial fermentation of nutrients (e.g. propionate and butyrate). These molecules are highly abundant and circulatory (have body-wide effects) in the body and their levels can be manipulated via genetic engineering of the gut microbiome. We will apply the genetic tools in the lab to toggle on/off these microbiota metabolites in vivo and investigate their effects on host intestinal immunity and IBD development.
3. Regulating the metabolic interaction between host and gut microbiota. The microbiome is one of the key orchestrators in mediating human health. We will use bioinformatics and molecular genetics to design and engineer a microbiota community for a predefined function in regulating host intestinal immunity for IBD treatment.
研究兴趣
论文共 52 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Ting-Ting Li, Xi Chen, Da Huo,Mohammad Arifuzzaman, Shanshan Qiao,Wen-Bing Jin, Huiqing Shi,Xin V. Li,Iliyan D. Iliev,David Artis,Chun-Jun Guo
Shushan Sargsian, Octavio Mondragon-Palomino, Alannah Lejeune, Defne Ercelen, Wen-Bing Jin, Alan Varghese,Yvonne A. L. Lim,Chun-Jun Guo, P'ng Loke, Ken Cadwell
MICROBIOMEno. 1 (2024)
Svetlana Lima,Silvia Pires, Amanda Rupert, Seun Oguntunmibi,Wen-Bing Jin,Chun-Jun Guo,Gabriela Funez-dePagnier, Grace Maldarelli,Monica Viladomiu, Wei Yang, Nancy Tran, Grace Xiang,
Gastroenterologyno. 5 (2024): S-116-101431
JOURNAL OF EXPERIMENTAL MEDICINEno. 5 (2024)
IMMUNITYno. 1 (2024): 14-27
Jingjing Cong, Pianpian Liu, Zili Han, Wei Ying,Chaoliang Li, Yifei Yang, Shuling Wang,Jianbo Yang,Fei Cao,Juntao Shen, Yu Zeng,Yu Bai,
Immunityno. 4 (2024): 876-889.e11
Nature immunologyno. 11 (2023): 1879-1889
Inflammatory Bowel Diseasesno. 4 (2023): S93-S93
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn